Isoniazid-induced hepatic necrosis and steatosis in rabbits: Absence of effect of gender

Canadian Journal of Physiology and Pharmacology

Volumn 75, Issue 9, 1997, Pages 1108-1111

  Sarich, Troy C ^a   Adams, Stephen P ^a   Zhou, Ting ^a   Wright, James M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Acetylation; Argininosuccinic acid lyase; Gender; Hepatic necrosis; Hepatic steatosis; Hypertriglyceridemia; Isoniazid; Sulfamethazine

Indexed keywords

ARGININOSUCCINATE LYASE; ISONIAZID; SULFADIMIDINE; TRIACYLGLYCEROL;

ACETYLATOR PHENOTYPE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME BLOOD LEVEL; FATTY LIVER; FEMALE; GENDER; INTRAVENOUS DRUG ADMINISTRATION; LIVER LEVEL; LIVER NECROSIS; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030782529     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y97-144     Document Type: Article

References (24)

1. Barlow, P.B., Black, M., Brummer, D.L., Comstock, G.W., Dubin, I.N., Enterline, P., Gibson, M.L., Hardy, G.E., Jr., Harrel, J.A., Johnston, R.F., Kent, D.C., Marvin, B.A., McCaig, N.C., Mitchell, J.R., Mosley, J.W., Ogasawara, F.R., Popper, H., Reichman, L.B., and Zimmerman, H.J. 1974. Preventive therapy of tuberculous infection. Am. Rev. Respir. Dis. 110: 371-374.
2. Black, M., Mitchell, J.R., Zimmerman, H.J., Ishak, K.G., and Epler, G.R. 1975. Isoniazid-associated hepatitis in 114 patients. Gastroenterology, 69: 289-302.
3. Blum, M., Grant, D.M., Demierre, A., and Meyer, U.A. 1989. N-Acetylation pharmacogenetics: a gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits. Proc. Natl. Acad. Sci. U.S.A. 86: 9554-9557.
4. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal. Biochem. 72: 248-254.
5. Campanini, R.Z., Tapia, R.A., Sarnat, W., and Natelson, S. 1970. Evaluation of serum argininosuccinate lyase (ASAL) concentrations as an index to parenchymal liver disease. Clin. Chem. 16: 44-53.
6. Fischer, C., and Klotz, U. 1978. Determination of sulfapyridine and its major metabolites in plasma by high-pressure liquid chromatography. J. Chromatogr. 146: 157-162.
7. Gent, W.L., Seifart, H.I., Parkin, D.P., Donald, P.R., and Lamprecht, J.H. 1992. Factors in hydrazine formation from isoniazid by paediatric and adult tuberculous patients. Eur. J. Clin. Pharmacol. 43: 131-136.
8. Gordon, G.R., Shafizadeh, A.G., and Peters, J.H. 1973. Polymorphic acerylation of drugs in rabbits. Xenobiotica, 3: 133-150.
9. Jenner, A.M., and Timbrell, J.A. 1994. Influence of inducers and inhibitors of cytochrome P450 on the hepatotoxicity of hydrazine in vivo. Arch. Toxicol. 68: 349-357.
10. Karthikeyan, S., and Krishnamoorthy, M.S. 1991. Effect of subacute administration of isoniazid and pyridoxine on lipids in plasma, liver, and adipose tissues in the rabbit. Drug Chem. Toxicol. 14: 293-303.
11. Lamb, R.G., and Banks, W.L. 1979. Effect of hydrazine exposure on hepatic triacylglycerol biosynthesis. Biochim. Biophys. Acta, 574; 440-447.
12. McKennis, H., Jr., Yard, A.S., and Pahnelas, E.V. 1956. The production of fatty livers in rabbits by isoniazid and other hydrazine derivatives. Am. Rev. Tuberc. 73: 956-959.
13. Mitchell, J.R., Long, M.W., Thorgeirsson, U.P., and Jollow, D.J. 1975. Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy. Chest, 68: 181-190.
14. Moulding, T.S., Redeker, A.G., and Kanel, G.C. 1989. Twenty isoniazid-associated deaths in one state. Am. Rev. Respir. Dis. 140: 700-705.
15. Murray, C.J.L., Sryblo, K., and Rouillon, A. 1990. Tuberculosis in developing countries: burden, intervention and cost. Bull. Int. Union Tuberc. Lung Dis. 65: 6-24.
16. Noda, A., Hsu, K.-Y., Noda, H., Yamamoto, Y., and Kurozumi, T. 1983. Is isoniazid hepatotoxicity induced by the metabolite hydrazine? J. UOEH, 5: 183-190.
17. Pessayre, D., Bentata, M., Degott, C., Nouel, O., Miguet, J.P., Rueff, B., and Benhamou, J.-P. 1977. Isoniazid-rifampin fulminant hepatitis: a possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction. Gastroenterology, 72: 284-289.
18. Sarich, T.C., Adams, S.P., Zhou, T., and Wright, J.M. 1993. Isoniazid-induced hepatotoxicity in rabbits: a comparison of necrosis and steatosis. Clin. Invest. Med. 16: B67. (Abstr.)
19. Sarich, T.C., Zhou, T., Adams, S.P., Bain, A.I., Wall, R.A., and Wright, J.M. 1995. A model of isoniazid-induced hepatotoxicity in rabbits. J. Pharmacol. Toxicol. Methods, 34: 109-116.
20. Sarich, T.C., Youssefi, M., Zhou, T., Adams, S.P., Wall, R.A., and Wright, J.M. 1996. The role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbits. Arch. Toxicol. 70: 835-840.
21. Sims, F.H., and Rautanen, P. 1975. Serum arginino-succinate lyase: observations on the sensitivity and specificity of this test in the detection of minimal hepatocellular damage. Clin. Biochem. 8: 213-221.
22. Snider, D.E., and Caras, G.J. 1992. Isoniazid-associated hepatitis deaths: a review of available information. Am. Rev. Respir. Dis. 145: 494-497.
23. Vatsis, K.P., Weber, W.W., Bell, D.A., Dupret, J.-M., Price Evans, D.A., Grant, D.M., Hein, D.W., Lin, H.J., Meyer, U.A., Relling, M.V., Sim, E., Suzuki, T., and Yamazoe, Y. 1995. Nomenclature for N-acetyltransferases. Pharmacogenetics, 5: 1-17.
24. Woo, J., Chan, C.H.S., Walubo, A., and Chan, K.K.C. 1992. Hydrazine: a possible cause of isoniazid-induced hepatic necrosis. J. Med. 23: 51-59.